- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Current Guidelines & Unmet Needs In The Treatment of Agitation Associated With Alzheimer’s Dementia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Current Guidelines & Unmet Needs In The Treatment of Agitation Associated With Alzheimer’s Dementia
This is a Virtual Event for PsychU members in Illinois, Iowa, Kansas, Minnesota, Missouri, North Dakota, South Dakota, and Wisconsin.
Individualized and multimodal treatment plans are recommended for patients with Alzheimer’s disease and Agitation associated with Alzheimer’s Dementia (AAD). There is a need for better identification of AAD. There is also a need for approved pharmacological treatments that have proven and favorable benefit, risk profiles to reduce symptoms and ultimately improve burden to caregivers and healthcare.
In this discussion, current treatment guidelines, assess risk/benefit profile, and discuss unmet needs of AAD treatment will be reviewed.
Featuring
Maria Perez, PharmD, AAHIVP
Medical Science Liaison – Digital Therapeutics
Heather Fields, PharmD, MPH, BCACP (OPDC)
Medical Science Liaison
Speakers Maria Perez, PharmD, AAHIVP and Heather Fields, PharmD, MPH, BCACP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
Registration
Related Resources
-
The Agitation in Alzheimer’s Screener for Caregivers (AASC™) Scale Brochure
Downloadable Resource October 3, 2024The Agitation in Alzheimer’s Screener for Caregivers (AASC™) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed…
-
ICD-10-CM Diagnosis Code Quick Reference Guide
Infographic October 2, 2024This list includes ICD-10 codes that may be relevant for patients with agitation associated with dementia due to Alzheimer’s disease.
-
Talking Points (Part II): Primary Care on MDD – David Lewis
Podcast October 1, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Major Depressive Disorder (MDD) with special guest, David E….
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: